Cardiovascular Disorder clinical trials
176 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Virtual Care Strategies to Improve Participation in Cardiac Rehabilitation Among Veterans
- Impact of Cognitive Behavioral Therapy on PTSD-CVD Link
- SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation
- Optimizing Aerobic Fitness in Older Adults
- NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
- OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
- Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
- Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
- An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
- CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- Investigating Cardiac Health of Adults With Trauma
- Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
- A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors
- Secondhand Tobacco Smoke and Cardiovascular Disease
- Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
- Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
- Prevention of Progression of Prediabetes, Obesity and CV Risk
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
- GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
- LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
- Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans With Chronic Disease
- Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs
- Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program
- Philly CEAL- DECIDE+ Adaptation
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
- Techquity by FAITH!
- Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- Strong Teens for Healthy Schools Change Club: A Civic Engagement Approach to Improving Physical Activity and Healthy Eating Environments
- Mindfulness and Behavior Change to Improve Cardiovascular Health of Older People With HIV
- Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs
- A Pilot Feasibility and Acceptability Study of Remote ExerciSe Training mOdalities (PRESTO)
- Early Intervention to Promote Cardiovascular Health of Mothers and Children
- Enhancing Capacity in Churches to Implement PA Programs
- The Effects of Healthy Diets With Plant Oils on Heart and Metabolic Health
- Corazones Unidos Study
- Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial
- The Cooking for Health Optimization and Disease Prevention (CHOP) Trial
- HIIT Effects on Cardiometabolic Health
- Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
- Role of Adiposomes in Endothelial Dysfunction
- Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Cardiovascular Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.